Post-Injury Treatment with 7,8-Dihydroxyflavone, a TrkB Receptor Agonist, Protects against Experimental Traumatic Brain Injury via PI3K/Akt SignalingChun‐Hu Wu(National Defense Medical Center), Szu‐Fu Chen(Cheng Hsin General Hospital)PLoS ONENovember 21, 201410.1371/journal.pone.0113397Cited by 104SaveCiteExport RISWatch citationsRelated PapersSalidroside Improves Behavioral and Histological Outcomes and Reduces Apoptosis via PI3K/Akt Signaling after Experimental Traumatic Brain Injury|PLoS ONE|2012|83